Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01550510 · ClinicalTrials.gov registry record · Phase 1
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
A Phase 1 study, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01550510 is a Phase 1 study that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 4 participants.
The verdict
NCT01550510, a Phase 1 study, was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
This protocol is a phase I/II, study of ascorbic acid (AA) infusions combined with treatment with irinotecan versus treatment with irinotecan alone in patients with recurrent or advanced colorectal cancer who have failed at least one treatment regimen with a 5-FU based therapy. This study will be conducted as an amendment to Investigational New Drug # 77486.
Interventions
- DRUG Irinotecan
- DRUG Ascorbic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01550510
The ClinicalTrials.gov registry entry for NCT01550510 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Irinotecan is the first listed.
NCT01550510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01550510 about?
NCT01550510 is a clinical study titled "Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA". This protocol is a phase I/II, study of ascorbic acid (AA) infusions combined with treatment with irinotecan versus treatment with irinotecan alone in patients with recurrent or advanced colorectal cancer who have failed at least one treatment regimen with a 5-FU based therapy. This study will be co...
What is the current status of trial NCT01550510?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2011-12. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01550510?
The interventions under investigation include: Irinotecan (DRUG), Ascorbic Acid (DRUG).
Who is sponsoring clinical trial NCT01550510?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.